Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves Moderna
Key Points: In today’s Recommendation for Industry, we discuss the westward movement of COVID and increase of BA.4 and BA. 5 in the U.S. Read
Key Points: In today’s Recommendation for Industry, we discuss how cases seem to be improving and moving across the country, as shown through the CDC
Key Points: In today’s Recommendations for Industry, we discuss COVID-19 trends stabilizing and declining. Read more below. The CDC released research done on post-COVID conditions
Key Points: In today’s Recommendations for Industry, we discuss the trends of COVID based on TAG’s weekly matrix and the CDC community levels mapping. Read
Key Points: In today’s Recommendations for Industry, we discuss the latest COVID transmissibility data from both TAG’s matrix and CDC’s mapping. Read more below. Today,
Key Points: In today’s Recommendations for Industry, we discuss the slight increase in cases around the U.S. Read more below. The FDA is warning consumers
Key Points: In today’s Recommendations for Industry, we discuss TAG’s weekly matrix and the “gentle swell” of COVID in the U.S. Read more below. CDC:
Key Points: In today’s Recommendations for Industry, we discuss low COVID levels across much of the U.S. with some regional levels of BA.2.12. Read more
Key Points: In today’s Recommendations for Industry, we discuss the current status of COVID and the conflicting news. Read more below. The CDC has extended
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
